Americans spend at least $100 billion each year on low back pain, a ubiquitous job-related disability and a leading contributor to missed days of work. While the etiology of disc disease is multifactorial, there is general agreement that loss of water and a decrease in osmotic pressure compromises cellular function and exacerbates the disease state. We have recently shown that T1? MRI and Opening Pressure (OP), parameters of disc hydration and osmotic status, provide quantitative measures of both tissue degeneration and back pain. Despite recognition of these facts, molecular mechanisms that control the disc water content and osmotic pressure remain poorly understood. We have shown that TonEBP, the only known osmoresponsive transcription factor is expressed in the nucleus pulposus (NP) and is diminished in the disease state. Based on these findings, we propose to test an innovative overarching hypothesis: TonEBP activity is linked to osmotic status of the NP and correlates with T1? and OP and controls critical NP survival and functional activities;compromised TonEBP function promotes development of disease. To test this central hypothesis, first, we will measure the expression of TonEBP and its target genes in human degenerate discs in relationship to measures of hydration status and pain: T1? and OP. We will then define the importance of TonEBP by suppressing its expression and evaluating its effects on NP cell apoptosis, autophagy and senescence. Second, we will determine the mechanism by which TonEBP controls expression of water transporters (aquaporins) and proteoglycans, molecules required for the maintenance of the osmotic properties of the disc. In addition, we will measure expression of key enzymes required for glycan synthesis and sulfation. We will determine if the disease process has altered the ability of TonEBP to respond to osmotic shifts. We will ascertain if restoration of TonEBP activity in diseased human cells using angiotensin II (ANG II), PDGF-BB or TonEBP expression plasmid stimulates matrix synthesis and aquaporin levels. The third goal of the investigation is to determine if inactivation of TonEBP compromises osmotic and biomechanical properties of the disc in vivo. Using lentiviral-ShTonEBP injection in rat discs and conditional inactivation of TonEBP in TonEBPf/f mice, we will determine if suppression causes alterations in T1? signal, matrix composition and biomechanical properties of the disc. Finally, using a well characterized rat model of disc disease, we will attempt to restore TonEBP expression/activity using either PDGF-BB or ANG II and monitor changes. Outcomes from these studies will provide foundation for innovative strategies aimed at restoring osmotic and water balance mediated through TonEBP, thereby delaying the development or progression of degenerative disc disease in the aging spine.

Public Health Relevance

Lower back pain experienced by millions of aging Americans is closely linked to degenerative disc disease, a condition that afflicts the spine. During degeneration, dehydration causes a decrease in intervertebral disc height. The goal of the proposal is to understand the mechanisms that control the water binding properties of the disc and develop new non-surgical strategies for the prevention and treatment of the disease.

Agency
National Institute of Health (NIH)
Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Type
Research Project (R01)
Project #
1R01AR064733-01A1
Application #
8702640
Study Section
Skeletal Biology Structure and Regeneration Study Section (SBSR)
Program Officer
Tyree, Bernadette
Project Start
2014-04-01
Project End
2019-03-31
Budget Start
2014-04-01
Budget End
2015-03-31
Support Year
1
Fiscal Year
2014
Total Cost
$447,913
Indirect Cost
$169,670
Name
Thomas Jefferson University
Department
Orthopedics
Type
Schools of Medicine
DUNS #
053284659
City
Philadelphia
State
PA
Country
United States
Zip Code
19107
Schoepflin, Zachary R; Shapiro, Irving M; Risbud, Makarand V (2016) Class I and IIa HDACs Mediate HIF-1α Stability Through PHD2-Dependent Mechanism, While HDAC6, a Class IIb Member, Promotes HIF-1α Transcriptional Activity in Nucleus Pulposus Cells of the Intervertebral Disc. J Bone Miner Res 31:1287-99
Suyama, Kaori; Silagi, Elizabeth S; Choi, Hyowon et al. (2016) Circadian factors BMAL1 and RORα control HIF-1α transcriptional activity in nucleus pulposus cells: implications in maintenance of intervertebral disc health. Oncotarget 7:23056-71
Tian, Ye; Yuan, Wen; Li, Jun et al. (2016) TGFβ regulates Galectin-3 expression through canonical Smad3 signaling pathway in nucleus pulposus cells: implications in intervertebral disc degeneration. Matrix Biol 50:39-52
Binch, Abbie L A; Shapiro, Irving M; Risbud, Makarand V (2016) Syndecan-4 in intervertebral disc and cartilage: Saint or synner? Matrix Biol 52-54:355-62
Choi, Hyowon; Johnson, Zariel I; Risbud, Makarand V (2015) Understanding nucleus pulposus cell phenotype: a prerequisite for stem cell based therapies to treat intervertebral disc degeneration. Curr Stem Cell Res Ther 10:307-16
Ye, Wei; Zhou, Jie; Markova, Dessislava Z et al. (2015) Xylosyltransferase-1 expression is refractory to inhibition by the inflammatory cytokines tumor necrosis factor α and IL-1β in nucleus pulposus cells: novel regulation by AP-1, Sp1, and Sp3. Am J Pathol 185:485-95
Shapiro, Irving M; Landis, William J; Risbud, Makarand V (2015) Matrix vesicles: Are they anchored exosomes? Bone 79:29-36
Johnson, Z I; Schoepflin, Z R; Choi, H et al. (2015) Disc in flames: Roles of TNF-α and IL-1β in intervertebral disc degeneration. Eur Cell Mater 30:104-16; discussion 116-7
Johnson, Zariel I; Gogate, Shilpa S; Day, Rebecca et al. (2015) Aquaporin 1 and 5 expression decreases during human intervertebral disc degeneration: Novel HIF-1-mediated regulation of aquaporins in NP cells. Oncotarget 6:11945-58
Risbud, Makarand V; Schoepflin, Zachary R; Mwale, Fackson et al. (2015) Defining the phenotype of young healthy nucleus pulposus cells: recommendations of the Spine Research Interest Group at the 2014 annual ORS meeting. J Orthop Res 33:283-93

Showing the most recent 10 out of 15 publications